Daniel Simon

Corporate Officer/Principal at IDEAYA BIOSCIENCES, INC.

Health Technology

Consumer Services

Health Services

Profile

Daniel A. Simon currently works at IDEAYA Biosciences, Inc., as Chief Business Officer from 2024.
Mr. Simon also formerly worked at Revolution Medicines, Inc., as Chief Business Officer from 2022 to 2024 and Guardant Health, Inc., as Senior VP-Biopharma Business Development from 2015 to 2022.
Mr. Simon received his graduate degree from the University of Cambridge and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Daniel Simon active positions

Companies	Position	Start
IDEAYA BIOSCIENCES, INC.	Corporate Officer/Principal	31/07/2024

All active positions of Daniel Simon

Former positions of Daniel Simon

Companies	Position	End
REVOLUTION MEDICINES, INC.	Corporate Officer/Principal	31/12/2023
GUARDANT HEALTH, INC.	Corporate Officer/Principal	31/12/2021

See the detail of Daniel Simon's experience

Training of Daniel Simon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Simon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Guardant Health, Inc. Guardant Health, Inc. Medical/Nursing ServicesHealth Services Develops diagnostic technologies to improve cancer management	Health Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Revolution Medicines, Inc. Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products	Health Technology
IDEAYA Biosciences, Inc. IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics	Health Technology